We are taking our innovative diabetic eye screening software, Spectra, to EASDec 2015 in Turin from 26th-28th June. If you are attending please come along for a chat about how the software can fully support your patient’s journey through the screening pathway as it is a cost effective tool as numerous eye conditions can be identified.
is a Study Group of the European Association for the Study of Diabetes (EASD) with special focus on the study of the eye complications of diabetes. Its aim is to promote the advancement of knowledge of all aspects of diabetic retinopathy, including epidemiology, pathology, pathophysiology, investigation and treatment through active collaboration between Ophthalmologists and Diabetologists. The ultimate goal of the Group is to prevent the development of diabetic retinopathy and to search for the best treatment of this condition in diabetic patients.